<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:fnd="http://xbrl.sec.gov/fnd/2026"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ft13133-20260812.xsd" xlink:type="simple"/>
    <context id="AsOf2026-08-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002133410</identifier>
        </entity>
        <period>
            <startDate>2026-08-12</startDate>
            <endDate>2026-08-12</endDate>
        </period>
    </context>
    <context id="From2026-08-112026-08-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002133410</identifier>
        </entity>
        <period>
            <startDate>2026-08-11</startDate>
            <endDate>2026-08-11</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="AsOf2026-08-12" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-08-12" id="Fact000004">0002133410</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2026-08-12" id="Fact000010">S-6</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="AsOf2026-08-12" id="Fact000011">FT 13133</dei:EntityRegistrantName>
    <dei:DocumentPeriodEndDate contextRef="From2026-08-112026-08-11" id="Fact000012">2026-08-12</dei:DocumentPeriodEndDate>
    <fnd:NmRule35d1TermDfnTextBlock contextRef="AsOf2026-08-12" id="Fact000013">

&lt;p style="font: bold 11pt/12pt Times New Roman, Times, Serif; margin: 4pt 0 1pt"&gt;Objective.&lt;/p&gt;

&lt;p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 2pt 0; text-indent: 0.25in"&gt;&lt;span style="letter-spacing: -0.05pt"&gt;The
Trust seeks above-average capital appreciation&lt;/span&gt;. The Trust is concentrated &lt;span style="letter-spacing: -0.05pt"&gt;(i.e., invests
25% or more of Trust assets) &lt;/span&gt;in common stocks of companies within the industrials sector.&lt;/p&gt;

</fnd:NmRule35d1TermDfnTextBlock>
    <fnd:NmRule35d1TermSlctnCritTextBlock contextRef="AsOf2026-08-12" id="Fact000014">

&lt;p style="font: bold 11pt/12pt Times New Roman, Times, Serif; margin: 4pt 0 1pt"&gt;Portfolio Selection Process.&lt;/p&gt;

&lt;p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 0 2pt; text-indent: 0.25in"&gt;&lt;span style="letter-spacing: -0.05pt"&gt;Tactical
asset allocation is an active investment strategy where portfolio managers make short term adjustments to a mix of assets to capitalize
on perceived market opportunities or economic shifts, deviating temporarily from a long-term strategic plan to enhance returns or manage
risk.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0 0 2pt; text-indent: 0.25in"&gt;&lt;span style="letter-spacing: -0.05pt"&gt;The
portfolio consists of companies from the following areas which have been identified by our team of analysts based on their current market
outlook.&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Sectors &#x2013; 50%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 71%; text-indent: 0.25in"&gt;Financials&lt;/td&gt;
    &lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 17%; text-align: right"&gt;10&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 0.25in"&gt;Health Care&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;10&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.25in"&gt;Industrials&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;20&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 0.25in"&gt;Information Technology&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;10&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Themes &#x2013; 50%&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 0.25in"&gt;A/I Robotics&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;10&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0.25in"&gt;Biotechnology&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;10&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 0.25in"&gt;International Capital Strength&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;10&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 0.25in"&gt;SMid Capital Strength&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;20&lt;/td&gt;
    &lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: bold 2pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 2pt/2pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt/10pt Times New Roman, Times, Serif; margin: 0 0 2pt; text-indent: 0.25in"&gt;&lt;span style="letter-spacing: -0.05pt"&gt;While
not a part of the Trust&#x2019;s portfolio selection process, the Trust also invests in dividend-paying securities, depositary receipts
and large capitalization companies. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/10pt Times New Roman, Times, Serif; margin: 0 0 2pt; text-indent: 0.25in"&gt;&lt;span style="letter-spacing: -0.05pt"&gt;As
with any similar investments, there can be no assurance that the objective of the Trust will be achieved. See &#x201c;Risk Factors&#x201d;
for a discussion of the risks of investing in the Trust.&lt;/span&gt;&lt;/p&gt;

</fnd:NmRule35d1TermSlctnCritTextBlock>
</xbrl>
